Any current/future new fundraising through debt or equity?

There is no mention of any current or planned fundraising through debt or equity in the transcript. The company continues to maintain a zero long-term debt position, reflecting a very low debt-equity ratio. No discussions or indications about raising capital via equity are presented. Focus appears to be on internal growth, expanding manufacturing and distribution, acquiring land for future projects, and strengthening R&D. Financial strategy highlights maintaining healthy return on equity and capital employed without resorting to debt financing.

Any current/future capex/capital investment/strategic investment?

The company is setting up a new R&D facility, with work underway and expected completion by the end of the calendar year. They are developing Polyacrylamide Solid technology, targeting an initial planned capacity of 10,000 MT per annum, expected to add substantially to revenue once commercialized. Black Rose is actively acquiring about 20 acres of land to create a land bank for future manufacturing projects, aiming to reduce delays and enhance project viability. They are progressing with an Environmental Clearance (EC) application for a new specialty chemicals project, hoping to secure clearan

Future growth expectations in sales/revenue/volumes?

The company is focused on maximizing sales and profits in both distribution and manufacturing setups. Stable sales are expected in the chemical distribution segment, supported by strong material availability and pricing from key principals. Domestic volumes are projected to remain steady. Merchant exports, especially to the US oil & gas sector, are anticipated to pick up, aiding volume growth. Introduction of new products during the current and upcoming quarters is expected to expand the distribution portfolio. Acrylamide Liquid market share is likely to grow locally as raw material prices sta

Future growth expectations in earnings/operating earnings/profits/EPS?

Company is progressing well with focus on maximizing sales and profits in both distribution and manufacturing. Expect stable sales in the distribution business supported by strong principal relationships and market share expansion. Manufacturing volumes to improve supported by stabilization of raw material prices and new product traction (e.g., Polyacrylamide Liquid binder). R&D efforts underway for Polyacrylamide Solid with potential commercial capacity of 10,000 MT/year to add substantially to the top line. Expect improvement in margins as raw material prices have stabilized and are slightly

Current/ Expected Orderbook/ Pending Orders?

The transcript does not explicitly mention the current or expected order book or pending orders. However, it indicates strong demand and steady order consistency in key products such as N-methylol acrylamide (NMA), which is expected to result in a steady quarter. The company’s sales team is actively expanding market share and introducing new products, implying a positive outlook on orders. Merchant exports, especially to the US oil & gas sector, are picking up, supporting increased sales volumes. The company is focused on maximizing sales and profits in both distribution and manufactur

Black Rose Industries LtdQ2 FY25Chemicals & Petrochemicals

Black Rose Industries Ltd Q2 FY25 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹110P/E: 20.6Market Cap: ₹591 CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3

The company is focused on maximizing sales and profits in both distribution and manufacturing setups.
Stable sales are expected in the chemical distribution segment, supported by strong material availability and pricing from key principals.
Domestic volumes are projected to remain steady.
Merchant exports, especially to the US oil & gas sector, are anticipated to pick up, aiding volume growth.
Introduction of new products during the current and upcoming quarters is expected to expand the distribution portfolio.
Acrylamide Liquid market share is likely to grow locally as raw material prices stabilize.
Export volumes for manufacturing products are expected to increase with improving international logistics.
The new robust binder for Polyacrylamide Liquid is receiving good market traction, likely improving sales volumes.
N-methylol acrylamide sales are expected to be steady with consistent orders from key customers.
Future projects are supported by strategic land acquisition to enable quicker manufacturing capacity expansion.

Margin guidance

Category 3

Company is progressing well with focus on maximizing sales and profits in both distribution and manufacturing.
Expect stable sales in the distribution business supported by strong principal relationships and market share expansion.
Manufacturing volumes to improve supported by stabilization of raw material prices and new product traction (e.g., Polyacrylamide Liquid binder).
R&D efforts underway for Polyacrylamide Solid with potential commercial capacity of 10,000 MT/year to add substantially to the top line.
Expect improvement in margins as raw material prices have stabilized and are slightly increasing.
New robust binder product showing good market response expected to boost sales volumes.
Retaining and acquiring talent to strengthen operational efficiency.
Overall, growth is expected in earnings and operating profits driven by expanding product portfolio, market share gains, and new manufacturing capacities.

See what Black Rose Industries Ltd management said on margin guidance — free account, 30 seconds.

Fundraise plans

There is no mention of any current or planned fundraising through debt or equity in the transcript.
The company continues to maintain a zero long-term debt position, reflecting a very low debt-equity ratio.
No discussions or indications about raising capital via equity are presented.
Focus appears to be on internal growth, expanding manufacturing and distribution, acquiring land for future projects, and strengthening R&D.
Financial strategy highlights maintaining healthy return on equity and capital employed without resorting to debt financing.

Order book

The transcript does not explicitly mention the current or expected order book or pending orders.
However, it indicates strong demand and steady order consistency in key products such as N-methylol acrylamide (NMA), which is expected to result in a steady quarter.
The company’s sales team is actively expanding market share and introducing new products, implying a positive outlook on orders.
Merchant exports, especially to the US oil & gas sector, are picking up, supporting increased sales volumes.
The company is focused on maximizing sales and profits in both distribution and manufacturing, suggesting ongoing healthy order inflow.
The acquisition and earmarking of 20 acres of land for future projects indicate preparation for scaling up operations and expected future orders.

See what Black Rose Industries Ltd management said on order book — free account, 30 seconds.

Capex plans

Yes

The company is setting up a new R&D facility, with work underway and expected completion by the end of the calendar year.
They are developing Polyacrylamide Solid technology, targeting an initial planned capacity of 10,000 MT per annum, expected to add substantially to revenue once commercialized.
Black Rose is actively acquiring about 20 acres of land to create a land bank for future manufacturing projects, aiming to reduce delays and enhance project viability.
They are progressing with an Environmental Clearance (EC) application for a new specialty chemicals project, hoping to secure clearances soon.
Strategic focus is on expanding manufacturing capacities for different products based on strong distribution relationships.
No specific announced capex amounts are mentioned, but these indicate ongoing and planned investments for growth and efficiency.

Track Black Rose Industries Ltd — get its next earnings analysis in your feed

How does Black Rose Industries Ltd rank vs peers in Chemicals & Petrochemicals?

Pro feature

ThisBlack Rose Industries Ltd

Rev 3Mar 3

See where Black Rose Industries Ltd sits in Chemicals & PetrochemicalsSee which companies these are, and every other name in the sector.Open rankings

How does Black Rose Industries Ltd rank in Chemicals & Petrochemicals?

Compare Black Rose Industries Ltd against every Chemicals & Petrochemicals company (Q2 FY25) on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

What Black Rose Industries Ltd's management said in earlier quarters

Others in Chemicals & Petrochemicals this season

Prasol Chemicals Ltd (Q1 FY27)
Q1 FY27 Revenue from Operations: ₹433.6 crores . Key investor presentation takeaways from Prasol Chemicals Ltd's Q1 FY27 investor presentation — and how it rank
Vipul Organics Ltd (Q4 FY26)
Q4 FY26 (Mar 2026) total revenue: ₹5,262.37 lakhs (Consolidated) . Key concall takeaways from Vipul Organics's Q4 FY26 earnings call — and how it ranks against…
Vipul Organics Ltd (Q1 FY27)
Q1 FY27 net revenue: ₹51.78 crore, up +37.7% YoY (Page 13) . Key concall takeaways from Vipul Organics's Q1 FY27 earnings call — and how it ranks against…
Fine Organic Industries Ltd (Q1 FY27)
Revenue from Operations (Consolidated) for Q1FY27: Rs 694.2 Cr, up 18.0% YoY from Rs 588.4 Cr in Q1FY26 (Page 34). Key concall takeaways from Fine Organic…

Compare:vs Solar Industries India Ltd vs Pidilite Inds.vs SRF Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Black Rose Industries Ltd Q2 FY25 Earnings Call Analysis

Revenue guidance

Fundraise plans

Capex plans

How does Black Rose Industries Ltd rank in Chemicals & Petrochemicals?

Continue your research

What Black Rose Industries Ltd's management said in earlier quarters

Others in Chemicals & Petrochemicals this season